Integrating randomized controlled trials and non-randomized studies of interventions to assess the effect of rare events: a Bayesian re-analysis of two meta-analyses

被引:2
作者
Zhou, Yun [1 ,2 ,3 ,4 ]
Yao, Minghong [1 ,2 ,3 ,5 ,6 ]
Mei, Fan [1 ,2 ,3 ,5 ,6 ]
Ma, Yu [1 ,2 ,3 ,5 ,6 ]
Huan, Jiayidaer [1 ,2 ,3 ,5 ,6 ]
Zou, Kang [1 ,2 ,3 ,5 ,6 ]
Li, Ling [1 ,2 ,3 ,5 ,6 ]
Sun, Xin [1 ,2 ,3 ,5 ,6 ,7 ,8 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guo Xue Xiang, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, 37 Guo Xue Xiang, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Ctr & MAGIC China Ctr, Cochrane China, 37 Guo Xue Xiang, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, President & Deans Off, Chengdu, Peoples R China
[5] Sichuan Univ, West China Hosp, NMPA Key Lab Real World Data Res & Evaluat Hainan, Chengdu, Peoples R China
[6] Sichuan Univ, West China Hosp, Sichuan Ctr Technol Innovat Real World Data, Chengdu, Peoples R China
[7] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Biostat, Chengdu, Peoples R China
[8] Sichuan Univ, West China Hosp 4, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
Meta-analysis; Rare events; Non-randomized studies of interventions; Risk of bias; SYSTEMATIC REVIEWS; QUALITY;
D O I
10.1186/s12874-024-02347-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundThere is a growing trend to include non-randomised studies of interventions (NRSIs) in rare events meta-analyses of randomised controlled trials (RCTs) to complement the evidence from the latter. An important consideration when combining RCTs and NRSIs is how to address potential bias and down-weighting of NRSIs in the pooled estimates. The aim of this study is to explore the use of a power prior approach in a Bayesian framework for integrating RCTs and NRSIs to assess the effect of rare events.MethodsWe proposed a method of specifying the down-weighting factor based on judgments of the relative magnitude (no information, and low, moderate, serious and critical risk of bias) of the overall risk of bias for each NRSI using the ROBINS-I tool. The methods were illustrated using two meta-analyses, with particular interest in the risk of diabetic ketoacidosis (DKA) in patients using sodium/glucose cotransporter-2 (SGLT-2) inhibitors compared with active comparators, and the association between low-dose methotrexate exposure and melanoma.ResultsNo significant results were observed for these two analyses when the data from RCTs only were pooled (risk of DKA: OR = 0.82, 95% confidence interval (CI): 0.25-2.69; risk of melanoma: OR = 1.94, 95%CI: 0.72-5.27). When RCTs and NRSIs were directly combined without distinction in the same meta-analysis, both meta-analyses showed significant results (risk of DKA: OR = 1.50, 95%CI: 1.11-2.03; risk of melanoma: OR = 1.16, 95%CI: 1.08-1.24). Using Bayesian analysis to account for NRSI bias, there was a 90% probability of an increased risk of DKA in users receiving SGLT-2 inhibitors and an 91% probability of an increased risk of melanoma in patients using low-dose methotrexate.ConclusionsOur study showed that including NRSIs in a meta-analysis of RCTs for rare events could increase the certainty and comprehensiveness of the evidence. The estimates obtained from NRSIs are generally considered to be biased, and the possible influence of NRSIs on the certainty of the combined evidence needs to be carefully investigated.
引用
收藏
页数:13
相关论文
共 61 条
[1]   Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events [J].
Alkabbani, Wajd ;
Pelletier, Ryan ;
Gamble, John-Michael .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2021, 190 (08) :1572-1581
[2]   Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials [J].
Anglemyer, Andrew ;
Horvath, Hacsi T. ;
Bero, Lisa .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (04)
[3]   Meta-Analysis of Rare Binary Adverse Event Data [J].
Bhaumik, Dulal K. ;
Amatya, Anup ;
Normand, Sharon-Lise T. ;
Greenhouse, Joel ;
Kaizar, Eloise ;
Neelon, Brian ;
Gibbons, Robert D. .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2012, 107 (498) :555-567
[4]   Meta-analyses frequently pooled different study types together: a meta-epidemiological study [J].
Bun, Rene-Sosata ;
Scheer, Jordan ;
Guillo, Sylvie ;
Tubach, Florence ;
Dechartres, Agnes .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020, 118 :18-28
[5]   The utility of mixed-form likelihoods [J].
Cook, RJ ;
Farewell, VT .
BIOMETRICS, 1999, 55 (01) :284-288
[6]   A robust Bayesian bias-adjusted random effects model for consideration of uncertainty about bias terms in evidence synthesis [J].
Cruz, Ivette Raices ;
Troffaes, Matthias C. M. ;
Lindstrom, Johan ;
Sahlin, Ullrika .
STATISTICS IN MEDICINE, 2022, 41 (17) :3365-3379
[7]   Case studies to explore the optimal use of randomized and nonrandomized studies in evidence syntheses that use GRADE [J].
Cuello, Carlos A. ;
Morgan, Rebecca L. ;
Brozek, Jan ;
Verbeek, Jos ;
Thayer, Kris ;
Ansari, Mohammed T. ;
Guyatt, Gordon ;
Schunemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 152 :56-69
[8]   GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines [J].
Cuello-Garcia, Carlos A. ;
Santesso, Nancy ;
Morgan, Rebecca L. ;
Verbeek, Jos ;
Thayer, Kris ;
Ansari, Mohammed T. ;
Meerpohl, Joerg ;
Schwingshackl, Lukas ;
Katikireddi, Srinivasa Vittal ;
Brozek, Jan L. ;
Reeves, Barnaby ;
Murad, Mohammad H. ;
Falavigna, Maicon ;
Mustafa, Reem ;
Regidor, Deborah L. ;
Alexander, Paul Elias ;
Garner, Paul ;
Akl, Elie A. ;
Guyatt, Gordon ;
Schunemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2022, 142 :200-208
[9]  
Deeks J J, 2003, Health Technol Assess, V7, piii
[10]   The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions [J].
Downs, SH ;
Black, N .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1998, 52 (06) :377-384